ARCHIVES

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

This article is from The Cancer Letter archive.

Vol. 16 No. 29 | July 20, 1990

Download PDF Visit The Full Archive

Related Articles

Neurocognitive Deficits Affect Future Adult Employment

September 30, 2011

DCT Board Oks Limited Support For Development Of Neutron Therapy

March 31, 1978

DCT Advisors Approve Grants Program For Trials Of BRMs

March 10, 1995

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

July 29, 1983

In Brief: NCI Award 14 Contracts to Operate The Cancer Information Service

August 13, 1999

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 14, 2000